BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32819220)

  • 1. Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach.
    van Tol S; Mögling R; Li W; Godeke GJ; Swart A; Bergmans B; Brandenburg A; Kremer K; Murk JL; van Beek J; Wintermans B; Reimerink J; Bosch BJ; Reusken C
    Emerg Microbes Infect; 2020 Dec; 9(1):1965-1973. PubMed ID: 32819220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV.
    Ayouba A; Thaurignac G; Morquin D; Tuaillon E; Raulino R; Nkuba A; Lacroix A; Vidal N; Foulongne V; Le Moing V; Reynes J; Delaporte E; Peeters M
    J Clin Virol; 2020 Aug; 129():104521. PubMed ID: 32623350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.
    Burbelo PD; Riedo FX; Morishima C; Rawlings S; Smith D; Das S; Strich JR; Chertow DS; Davey RT; Cohen JI
    J Infect Dis; 2020 Jun; 222(2):206-213. PubMed ID: 32427334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.
    Algaissi A; Alfaleh MA; Hala S; Abujamel TS; Alamri SS; Almahboub SA; Alluhaybi KA; Hobani HI; Alsulaiman RM; AlHarbi RH; ElAssouli MA; Alhabbab RY; AlSaieedi AA; Abdulaal WH; Al-Somali AA; Alofi FS; Khogeer AA; Alkayyal AA; Mahmoud AB; Almontashiri NAM; Pain A; Hashem AM
    Sci Rep; 2020 Oct; 10(1):16561. PubMed ID: 33024213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
    Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays.
    DomBourian MG; Annen K; Huey L; Andersen G; Merkel PA; Jung S; Dominguez SR; Knight V
    J Immunol Methods; 2020 Nov; 486():112837. PubMed ID: 32828791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological differentiation between COVID-19 and SARS infections.
    Chia WN; Tan CW; Foo R; Kang AEZ; Peng Y; Sivalingam V; Tiu C; Ong XM; Zhu F; Young BE; Chen MI; Tan YJ; Lye DC; Anderson DE; Wang LF
    Emerg Microbes Infect; 2020 Dec; 9(1):1497-1505. PubMed ID: 32529906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients.
    Sun B; Feng Y; Mo X; Zheng P; Wang Q; Li P; Peng P; Liu X; Chen Z; Huang H; Zhang F; Luo W; Niu X; Hu P; Wang L; Peng H; Huang Z; Feng L; Li F; Zhang F; Li F; Zhong N; Chen L
    Emerg Microbes Infect; 2020 Dec; 9(1):940-948. PubMed ID: 32357808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2.
    Johnson M; Wagstaffe HR; Gilmour KC; Mai AL; Lewis J; Hunt A; Sirr J; Bengt C; Grandjean L; Goldblatt D
    J Clin Virol; 2020 Sep; 130():104572. PubMed ID: 32769024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.
    Ripperger TJ; Uhrlaub JL; Watanabe M; Wong R; Castaneda Y; Pizzato HA; Thompson MR; Bradshaw C; Weinkauf CC; Bime C; Erickson HL; Knox K; Bixby B; Parthasarathy S; Chaudhary S; Natt B; Cristan E; El Aini T; Rischard F; Campion J; Chopra M; Insel M; Sam A; Knepler JL; Capaldi AP; Spier CM; Dake MD; Edwards T; Kaplan ME; Scott SJ; Hypes C; Mosier J; Harris DT; LaFleur BJ; Sprissler R; Nikolich-Žugich J; Bhattacharya D
    Immunity; 2020 Nov; 53(5):925-933.e4. PubMed ID: 33129373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs.
    Van Elslande J; Decru B; Jonckheere S; Van Wijngaerden E; Houben E; Vandecandelaere P; Indevuyst C; Depypere M; Desmet S; André E; Van Ranst M; Lagrou K; Vermeersch P
    Clin Microbiol Infect; 2020 Nov; 26(11):1557.e1-1557.e7. PubMed ID: 32745595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
    Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID19 antibody detection using lateral flow assay tests in a cohort of convalescent plasma donors.
    Ragnesola B; Jin D; Lamb CC; Shaz BH; Hillyer CD; Luchsinger LL
    BMC Res Notes; 2020 Aug; 13(1):372. PubMed ID: 32762746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
    Grzelak L; Temmam S; Planchais C; Demeret C; Tondeur L; Huon C; Guivel-Benhassine F; Staropoli I; Chazal M; Dufloo J; Planas D; Buchrieser J; Rajah MM; Robinot R; Porrot F; Albert M; Chen KY; Crescenzo-Chaigne B; Donati F; Anna F; Souque P; Gransagne M; Bellalou J; Nowakowski M; Backovic M; Bouadma L; Le Fevre L; Le Hingrat Q; Descamps D; Pourbaix A; Laouénan C; Ghosn J; Yazdanpanah Y; Besombes C; Jolly N; Pellerin-Fernandes S; Cheny O; Ungeheuer MN; Mellon G; Morel P; Rolland S; Rey FA; Behillil S; Enouf V; Lemaitre A; Créach MA; Petres S; Escriou N; Charneau P; Fontanet A; Hoen B; Bruel T; Eloit M; Mouquet H; Schwartz O; van der Werf S
    Sci Transl Med; 2020 Sep; 12(559):. PubMed ID: 32817357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a commercially available SARS-CoV-2 serological immunoassay.
    Meyer B; Torriani G; Yerly S; Mazza L; Calame A; Arm-Vernez I; Zimmer G; Agoritsas T; Stirnemann J; Spechbach H; Guessous I; Stringhini S; Pugin J; Roux-Lombard P; Fontao L; Siegrist CA; Eckerle I; Vuilleumier N; Kaiser L;
    Clin Microbiol Infect; 2020 Oct; 26(10):1386-1394. PubMed ID: 32603801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.
    Meschi S; Colavita F; Bordi L; Matusali G; Lapa D; Amendola A; Vairo F; Ippolito G; Capobianchi MR; Castilletti C;
    J Clin Virol; 2020 Aug; 129():104539. PubMed ID: 32679298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of diagnostic performance of serology tests for COVID-19: impact of assay design and post-symptom-onset intervals.
    Wang H; Ai J; Loeffelholz MJ; Tang YW; Zhang W
    Emerg Microbes Infect; 2020 Dec; 9(1):2200-2211. PubMed ID: 32962560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome.
    Shaw AM; Hyde C; Merrick B; James-Pemberton P; Squires BK; Olkhov RV; Batra R; Patel A; Bisnauthsing K; Nebbia G; MacMahon E; Douthwaite S; Malim M; Neil S; Martinez Nunez R; Doores K; Mark TKI; Signell AW; Betancor G; Wilson HD; Galão RP; Pickering S; Edgeworth JD
    Analyst; 2020 Aug; 145(16):5638-5646. PubMed ID: 32638712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.